Integrated BioPharma, Inc. (OTCMKTS:INBP) Short Interest Up 600.0% in September

Integrated BioPharma, Inc. (OTCMKTS:INBP) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 700 shares, a growth of 600.0% from the August 31st total of 100 shares. Based on an average trading volume of 45,200 shares, the days-to-cover ratio is currently 0.0 days.

Integrated BioPharma Stock Performance

OTCMKTS:INBP remained flat at $0.25 during trading hours on Friday. Integrated BioPharma has a 52 week low of $0.16 and a 52 week high of $0.30. The stock has a market cap of $7.52 million, a PE ratio of 24.99 and a beta of 0.66. The business has a fifty day simple moving average of $0.21 and a 200 day simple moving average of $0.21.

Integrated BioPharma (OTCMKTS:INBP) last posted its quarterly earnings data on Friday, September 20th. The company reported $0.01 EPS for the quarter. The business had revenue of $12.75 million during the quarter. Integrated BioPharma had a return on equity of 0.59% and a net margin of 0.22%.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.